Intervention Protocol

Interleukin-11 for induction of remission in Crohn's disease

  1. Masih Tajdini1,*,
  2. Seyed Mohammad Reza Hosseini1,
  3. Seyed Amir Mirbagheri2,
  4. Amirhossein Modabbernia1

Editorial Group: Cochrane Inflammatory Bowel Disease and Functional Bowel Disorders Group

Published Online: 18 APR 2012

DOI: 10.1002/14651858.CD009822


How to Cite

Tajdini M, Hosseini SMR, Mirbagheri SA, Modabbernia A. Interleukin-11 for induction of remission in Crohn's disease (Protocol). Cochrane Database of Systematic Reviews 2012, Issue 4. Art. No.: CD009822. DOI: 10.1002/14651858.CD009822.

Author Information

  1. 1

    Roozbeh Psychiatric Hospital, Tehran University of Medical Sciences, Department of Psychiatry, Tehran, Iran

  2. 2

    Faculty of Medicine, Tehran University of Medical Science, Department of Gastroenterology, Amira'lam Hospital, Tehran, Iran

*Masih Tajdini, Department of Psychiatry, Roozbeh Psychiatric Hospital, Tehran University of Medical Sciences, South Kargar Street, Tehran, 13337, Iran. drmasih84@yahoo.com. tajdinimasih@yahoo.com.

Publication History

  1. Publication Status: New
  2. Published Online: 18 APR 2012

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

The primary objectives are to determine the efficacy and safety of IL-11 used for induction of remission in CD.